MoyoAssist Extracorporeal Ventricular Assist Device
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1号 高邮路16弄, 上海, 上海市, ChinaPhone Number
+86 51265825859Website
www.magassist.com.cnRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About MoyoAssist Extracorporeal Ventricular Assist Device
心擎医疗（苏州）股份有限公司, founded in May 2017, focuses on developing advanced life support platforms for critical care scenarios. The company specializes in artificial organ development, with products under research including a fully magnetic levitation artificial heart, minimally invasive artificial heart, next-generation ECMO, and warm organ transport platforms. Their target clients include healthcare institutions and professionals in the field of critical care and cardiology. The company aims to innovate and enhance medical technology to support patients with severe heart conditions and multi-organ failure.Explore more
MoyoAssist Extracorporeal Ventricular Assist Device Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MoyoAssist Extracorporeal Ventricular Assist Device your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if MoyoAssist Extracorporeal Ventricular Assist Device has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if MoyoAssist Extracorporeal Ventricular Assist Device had a recent Job posting/layoffs
Funding: Get notified immidiatlly once MoyoAssist Extracorporeal Ventricular Assist Device has new funding data
Earning: See what the market has to say on MoyoAssist Extracorporeal Ventricular Assist Device recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at MoyoAssist Extracorporeal Ventricular Assist Device
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MoyoAssist Extracorporeal Ventricular Assist Device is spiking on competitors!
MoyoAssist Extracorporeal Ventricular Assist Device, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when MoyoAssist Extracorporeal Ventricular Assist Device launches new products
Recommended Actions
Find VP level buyers at MoyoAssist Extracorporeal Ventricular Assist Device
Find 2 more new buyers
Company Profile Activity
Activity Insights
MoyoAssist Extracorporeal Ventricular Assist Device is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MoyoAssist Extracorporeal Ventricular Assist Device is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MoyoAssist Extracorporeal Ventricular Assist Device.
MoyoAssist Extracorporeal Ventricular Assist Device Tech Stack
A closer look at the technologies used by MoyoAssist Extracorporeal Ventricular Assist Device
See more technologies
MoyoAssist Extracorporeal Ventricular Assist Device News & Media
magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device
SUZHOU, China, Aug. 21, 2023 /PRNewswire/ -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device Program. This recognition from FDA has reaffirmed magAssist's unwavering dedication to technology innovation in the area of artificial heart in medical device industry. Interventional VADs have been proven as an efmagAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device
SUZHOU, China, Aug. 21, 2023 /PRNewswire/ -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device...MagAssist Introduces BreathMo ECMO System
MagAssist introduced its ECMO system BreathMo, which uses maglev technology to reduce the risk of blood damage.magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
SUZHOU, China, March 14, 2023 /PRNewswire/ -- magAssist Inc. ("magAssist"), an innovator of medical devices has been named in authoritative international medical technology magazine MedTech Outlook's list of Top 10 Medical Technology Companies in the Asia-Pacific Region in 2022 (Top 10...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding MoyoAssist Extracorporeal Ventricular Assist Device
Sign Up For FreeTo access detailed company insights
心擎医疗（苏州）股份有限公司, founded in May 2017, focuses on developing advanced life support platforms for critical care scenarios. The company specializes in artificial organ development, with products under research including a fully magnetic levitation artificial heart, minimally invasive artificial heart, next-generation ECMO, and warm organ transport plat... Read More
